EC Number   |
Expression |
Reference |
|---|
   3.4.22.15 | down |
fasting-induced cathepsin L expression is suppressed in the skeletal muscle of skeletal-muscle specific Foxo1-knockout mice and in the skeletal muscle of DN-FOXO1 mice |
711141 |
| 3.4.22.15 | down |
pretreatment of rats or primary DA neurons with 200 nM olomoucine results in a partial blockade of nuclear translocation of cathepsin L after 12 h 0.008 mg 6-hydroxydopamine exposure |
711637 |
| 3.4.22.15 | down |
proteolytic activity is reduced by the administration of phage clones of cathepsin L mimotopes |
712631 |
| 3.4.22.15 | more |
expression of cathepsin L is not elevated in non-malignant tumor cells |
712921 |
| 3.4.22.15 | up |
a significantly increased extracellular release of cathepsin L is observed after repeated irradiation with UVA up to four times |
711939 |
| 3.4.22.15 | up |
after Aeromonas hydrophila stimulation, the mRNA expression is up-regulated in hemocytes and hepatopancreas |
731834 |
| 3.4.22.15 | up |
cathepsin L increased level follows active Ras overexpression, the p38 MAPK inhibitor SB203580 produces an increase of cathepsin L content |
713010 |
| 3.4.22.15 | up |
cathepsin L mRNA expression is markedly increased in the skeletal muscle during fasting. The mouse Ctsl promoter is activated by FOXO1 |
711141 |
| 3.4.22.15 | up |
chronic sun exposure causes an increase in Cat L activity |
713516 |
| 3.4.22.15 | up |
CTSL1 mRNA is upregulated by P4 in endometrium |
707640 |
